Thus, one can hypothesize that an accumulation of glucosylceramides or GM2 in Parkinson’s disease could participate to the production of CCL2 and to the recruitment of CCR2+ leucocytes into the brain. This evidence concerns the gene CCR2 and Parkinson disease.